Advanced search
Start date
Betweenand

Establishment of a three-dimensional model to determine the pharmacological efficacy and safety of nitrofuran and indoles derivatives and evaluation of Histoplasma capsulatum infection

Grant number: 20/15586-4
Support Opportunities:Scholarships in Brazil - Doctorate (Direct)
Effective date (Start): April 01, 2021
Effective date (End): November 30, 2022
Field of knowledge:Health Sciences - Pharmacy
Principal Investigator:Ana Marisa Fusco Almeida
Grantee:Carolina Orlando Vaso
Host Institution: Faculdade de Ciências Farmacêuticas (FCFAR). Universidade Estadual Paulista (UNESP). Campus de Araraquara. Araraquara , SP, Brazil

Abstract

Histoplasma capsulatum is a fungus that causes Histoplasmosis, a systemic and endemic Mycosis worldwide. In Brazil, this Mycosis mainly affects the southeast region, causing real problems in public health. There is a limited number of antifungal drugs for the treatment of mycoses in general and, particularly of Histoplasmosis, which have significant adverse effects such as renal and hepatic toxicity. This factor added to the growing reports of antifungal resistance and the formation of biofilms by these fungi, makes the development of new antifungals more effective both against planktonic cells and form biofilms, which have reduced toxicity. Therefore, this work aims to verify the anti-Histoplasma activity of nitrofuran and indole derivatives, as well as to investigate its possible mechanism (s) of action. Also, it is intended to establish a three-dimensional model formed by lung cells for the study of the H. capsulatum-host interaction using molecular methodologies and to evaluate the toxicity of the compounds. Two strains of H. capsulatum, EH-315 and ATCC 26032 (G217-B) will be used. The compounds derived from nitrofurans and indoles were elaborated and produced by the research group of Prof. Dr. Luigi Scipione from the University of Rome, Italy. The sensitivity tests will be conducted according to document M27-A3, proposed by the Clinical and Laboratory Standards Institute (CLSI, 2008), with minor modifications. The minimum fungicidal concentration (CFM) will be performed. The most potent compounds will be subjected to cytotoxicity testing in three-dimensional and monolayer cultures of cell lines A549 and MRC-5. The compounds that obtain the best selectivity indexes will be evaluated for their ability to inhibit planktonic cells in the concentration of biofilm, initial biofilm, and mature biofilm. For this, the metabolic activities of biofilms (planktonic biofilm concentration, initial and mature) will be quantified by the method of reducing the tetrazolic salt XTT and Scanning Electron Microscopy (SEM) images will be obtained, to verify possible damage. To determine the mechanisms of action will be performed: the quantification of the membrane ergosterol, evaluation of the cell death mechanism by the Propidium Iodide (PI) and annexin (FITC) assay, the dosage of Reactive Oxygen Species (ROS), wall damage, and cell membrane by SEM, confocal microscopy and transmission microscopy. In addition, toxicity will be verified in larvae of Caenorhabditis elegans, teratogenicity in Zebrafish embryos, and mutagenicity by micronucleus test. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications (5)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
BILA, NIURA MADALENA; COSTA-ORLANDI, CAROLINE BARCELOS; VASO, CAROLINA ORLANDO; BONATTI, JEAN LUCAS CARVALHO; DE ASSIS, LETICIA RIBEIRO; REGASINI, LUIS OCTAVIO; FONTANA, CARLA RAQUEL; FUSCO-ALMEIDA, ANA MARISA; MENDES-GIANNINI, MARIA JOSE SOARES. 2-Hydroxychalcone as a Potent Compound and Photosensitizer Against Dermatophyte Biofilms. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, v. 11, . (18/02785-9, 19/22188-8, 20/15586-4, 17/18388-6)
VASO, CAROLINA ORLANDO; BILA, NIURA MADALENA; PANDOLFI, FABIANA; DE VITA, DANIELA; BORTOLAMI, MARTINA; CARVALHO BONATTI, JEAN LUCAS; DE MORAES SILVA, ROSANGELA APARECIDA; CARVALHO GONCALVES, LARISSA NAIARA; TUDINO, VALERIA; COSTI, ROBERTA; et al. Evaluation of the Anti-Histoplasma capsulatum Activity of Indole and Nitrofuran Derivatives and Their Pharmacological Safety in Three-Dimensional Cell Cultures. PHARMACEUTICS, v. 14, n. 5, p. 23-pg., . (20/15586-4, 19/22188-8, 18/02785-9, 17/18388-6, 16/11836-0)
COSTA-ORLANDI, CAROLINE B.; BILA, NIURA M.; BONATTI, JEAN LUCAS C.; VASO, CAROLINA O.; SANTOS, MARIANA B.; POLAQUINI, CARLOS R.; BIASIOLI, MARIANA M. SANTONI M.; HERCULANO, RONDINELLI D.; REGASINI, LUIS O.; FUSCO-ALMEIDA, ANA MARISA; et al. Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of Dermatophytosis. PHARMACEUTICS, v. 15, n. 5, p. 19-pg., . (17/18388-6, 19/22188-8, 18/02785-9, 20/15586-4)
VASO, CAROLINA ORLANDO; PANDOLFI, FABIANA; BILA, NIURA MADALENA; DE VITA, DANIELA; BORTOLAMI, MARTINA; SOARES MENDES-GIANNINI, MARIA JOSE; TUDINO, VALERIA; COSTI, ROBERTA; COSTA-ORLANDI, CAROLINE BARCELOS; FUSCO-ALMEIDA, ANA MARISA; et al. Synthesis and Evaluation of the Antifungal and Toxicological Activity of Nitrofuran Derivatives. PHARMACEUTICS, v. 14, n. 3, p. 19-pg., . (20/15586-4, 16/11836-0, 19/22188-8, 17/18388-6)
FUSCO-ALMEIDA, ANA MARISA; SILVA, SAMANTA DE MATOS; DOS SANTOS, KELVIN SOUSA; GUALQUE, MARCOS WILLIAM DE LIMA; VASO, CAROLINA ORLANDO; CARVALHO, ANGELICA ROMAO; MEDINA-ALARCON, KAILA PETROLINA; PIRES, ANA CAROLINA MOREIRA DA SILVA; BELIZARIO, JENYFFIE ARAUJO; DE SOUZA FERNANDES, LIGIA; et al. Alternative Non-Mammalian Animal and Cellular Methods for the Study of Host-Fungal Interactions. JOURNAL OF FUNGI, v. 9, n. 9, p. 29-pg., . (20/15586-4, 21/14839-9, 21/03805-6, 19/23622-3)
Academic Publications
(References retrieved automatically from State of São Paulo Research Institutions)
VASO, Carolina Orlando. Establishment of a three-dimensional model to determine the pharmacological efficacy and safety of nitrofuran and indoles derivatives and evaluation of Histoplasma capsulatum infection. 2022. Doctoral Thesis - Universidade Estadual Paulista (Unesp). Faculdade de Ciências Farmacêuticas. Araraquara Araraquara.

Please report errors in scientific publications list using this form.